Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Perioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery
These symptoms are typically most pronounced during treatment initiation and often improve with continued use
For example, ABBV-969 is a novel PSMAxSTEAP1-directed bispecific ADC carrying a TOPI inhibitor payload with broader activity than ADCs targeting only PSMA or STEAP1 in preclinical mCRPC models, and is undergoing a phase I trial in mCRPC patients (NCT06318273) 120
Its been used in a one-hundred-year-old person
US$ 26.66
US$ 28.70
US$ 23.87
US$ 28.30
US$ 23.54
